![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
The current study was conducted to construct and validate a computer-delivered, multimedia, substance use self-assessment for adolescents. Reliability and validity of six problem dimensions were evaluated in two studies, conducted from 2003 to 2008. Study 1 included 192 adolescents from five treatment settings throughout the United States (N = 142) and two high schools from Greater Boston, Massachusetts (N = 50). Study 2 included 356 adolescents (treatment: N = 260; school: N = 94). The final version of Comprehensive Health Assessment for Teens (CHAT) demonstrated relatively strong psychometric properties. The limitations and implications of this study are noted. This study was supported by an SBIR grant.
RÉSUMÉ
CHAT: Development et validation d’un questionnaire auto-administré utilisant les multimedia evaluant l’usage de substances par les adolescents
L’étude presente a été accomplie pour construire et valider un questionnaire auto-administré utilisant les multimedia évaluant l’usage de substances par les adolescents. La fiabilité et la validité de six dimensions a été évaluée dans deux études qui ont été accomplies de 2003 à 2008. L’étude 1 inclut 192 adolescents venant de cinq centres de traitement a travers les Etats-Unis (N = 142) et deux collèges de Boston et sa periphérie (Massachusetts) (N = 50). L’étude 2 inclut 356 adolescents (centre de traitement: N = 260; collège: N = 94). La version finale de CHAT a montré des propriétés psychométriques solides. Les limites et les implications de cette étude sont notées. Cette étude a été financée par une bourse pour la Recherche Innovative par les Petites Enterprises (Small Business Innovative Research).
RESUMEN
CHAT: Desarrollo y validación de un programa computarizado de auto evaluación para adolescentes, con el fin de valorar el consumo de sustancias ilícitas.
El presente estudio fue diseñado para desarrollar y validar una auto evaluación de consumo de sustancias ilícitas en la población adolescente; utilizando una herramienta multimedia computarizada. La confiabilidad y validez de seis dimensiones de problemas fueron evaluadas en dos estudios realizados del 2003 al 2008. El primer estudio incluyó 192 adolescentes. N = 142 de 5 centros de tratamiento en Estados Unidos y N = 50 de dos escuelas de bachillerato en el área metropolitana de Boston. El segundo estudio incluyó 356 adolescentes (en tratamiento: N = 260; escolares: N = 94). La versión final de CHAT mostró propiedades psicométricas relativamente fuertes. Las limitaciones e implicaciones de éste estudio se describen. Este estudio fue auspiciado por el “Small Business Innovative Research”.
THE AUTHORS
Sarah E. Lord, Ph.D., is a Principal Investigator with the Center for Technology and Health at National Development and Research Institutes. A clinical-developmental psychologist, Dr. Lord received her Ph.D. from the University of Colorado, Boulder, Colorado, and completed an internship and postdoctoral fellowship at the University of Wisconsin, Madison, Wisconsin. Dr. Lord's research activities focus on the development, evaluation, and dissemination of technology-based assessment and intervention tools for adolescent, young adult, and parent populations, primarily in the areas of substance abuse and HIV prevention. Current projects include use of online social networks as platforms for delivery of evidence-based risk prevention interventions, use of mobile technologies to promote HIV health service utilization, and technology-delivered parent training programs to promote communication about drug use prevention. Dr. Lord has served as Principal Investigator on numerous National-Institutes-of-Health-funded (NIH-funded) projects and works extensively with community leaders, health educators, and marketing professionals to develop strategies for sustainable dissemination and implementation of technology-based assessments and interventions.
Kimberlee J. Trudeau, Ph.D., is a Research Scientist at Inflexxion, Inc., in Newton, Massachusetts. She completed her Ph.D. in social psychology at the City University of New York Graduate Center and was actively involved in initiating the Behavioral Medicine Field of The Cochrane Collaboration. Dr. Trudeau has served as Principal Investigator on several Small Business Innovative Research (SBIR) grants from the NIH. She has published in the areas of evidence-based behavioral medicine, health education, and women's health.
Ryan A. Black, Ph.D., is Director of Biostatistics & Methodology at Inflexxion, Inc., in Newton, Massachusetts. He earned his Ph.D. in Clinical Psychology from the Nova Southeastern University in Citation2006. As part of his training, he completed a predoctoral internship at the Harvard Medical School and a postdoctoral fellowship at the Yale School of Medicine. After completing his fellowship in 2007, Dr. Black joined faculty in the Psychiatry Department at the Yale School of Medicine, where he worked on various projects ranging from scale development and validation to phase II clinical trials. Dr. Black is also a clinical instructor in the Department of Psychiatry at the Harvard Medical School. He also teaches an undergraduate level statistics course at the Quinnipiac University on a regular basis.
Lucy Lorin has a B.A. and a Diploma in Fine Arts. She has worked for over 9 years supporting content development and coordinating research trials on NIH and US Department of Education grants. She specializes in grants related to children and adolescents and is particularly interested in researching the uses of technology to improve mental health and education outcomes. Ms. Lorin is a Coauthor of Draft: Builder software, a research-tested software created to support students with learning disabilities with writing skills. She is currently volunteering with Dr. Minna Levine who has created a Web application to support caregivers of children with autism track behavior during activity of daily living skills.
Elizabeth Cooney, M.P.H., C.H.E.S., has a Masters Degree in Public Health from the Boston University School of Public Health. She has over 5 years experience in project management managing NIH-funded grants and pharmaceutical-industry-sponsored educational initiatives. Ms. Cooney's research interests and primary areas of expertise include college health and technology-based social behavioral health interventions. Ms. Cooney is also a Certified Health Education Specialist.
Albert J. Villapiano, Ed.D., is Vice President of Clinical Development for Inflexxion, Inc., in Newton, Massachusetts, and is in charge of the behavioral health product line. He is also a licensed Psychologist who received his doctorate from the Boston University in 1983. Dr. Villapiano has over 25 years of experience as a clinician, trainer, researcher, administrator, and consultant. He is a Coprincipal Investigator on several NIH grants at Inflexxion and has been involved in the development and implementation of innovative processes and tools to improve the quality of behavioral health assessment, treatment, and education. He leads Inflexxion's efforts in the ongoing clinical enhancement of the Addiction Severity Index—Multimedia Version (ASI-MV) Connect system and its implementation nationwide. He has held academic appointments at the Harvard University, the Boston University Medical Schools, and the Northeastern Society for Group Psychotherapy Training Program. Among his publications is Time-Effective Treatment: A Best Practices Manual for Substance Abuse Professionals (2003). Chiauzzi, E., Villapiano, A., Budman, S., & Goldman, R., Center City, MN: Hazelden Foundation.
Stephen F. Butler, Ph.D., is Senior Vice President and Chief Science Officer at Inflexxion, Inc., in Newton, Massachusetts. Inflexxion develops scientifically based, interactive technologies that reduce health-related risks, enhance clinical outcomes, and positively influence quality of care. Dr. Butler received his Ph.D. in psychology from the Emory University in Atlanta, completed a clinical internship and advanced internship at the West Haven VA Medical Center and Yale Medical School, and was a National Institute of Mental Health (NIMH) Postdoctoral Fellow at the Vanderbilt University. In 1994, he joined Inflexxion as a Principal. He has experience and interest in a variety of behavioral health research areas, including psychotherapy, substance abuse, psychometrics and measurement, and, more recently, epidemiological approaches to population-based understanding of behavioral health issues. Dr. Butler is or has been Principal Investigator on more than 35 NIH grants. He has more than 80 peer-reviewed journal articles, books, and chapters and has presented at numerous national and international conferences. He is currently working on measuring the public health impact of abuse-deterrent formulations of prescription opioid analgesic medications, developing assessment technology that will enhance the treatment of chronic pain, and creating a computer adaptive testing (CAT) assessment of functional status of individuals with substance use disorders.